I can understand the book value being the biggest driver of the...

First 6 Last

Share
Profile

Follow
JoeGambler

1,236 Posts.

114

08/08/17

13:50

Post #: 26363064
Share

Originally posted by BrentT ↑

MNY have a history of exceeding guidance so it wouldn't surprise me if NPAT came in around $28.5-30 mil.

I do agree with JoeGambler that your dividend forecast is very optimistic. I'm expecting 2.75c for the dividend to keep the dividend flat between FY16 and FY17. They need the cash to reinvest so I don't think they can afford to raise the dividend. Particularly with the high borrowing costs.

In terms of valuation metrics, I don't think PE is a very good metric to use for MNY. Using $27.5 mil NPAT for FY17 and using NTA of ~$200 mill from the FY16 report and $218 mil from the HY report return on net tangible assets is around 13%.

At the current price, the market cap is around $233 mil which means the market is willing to pay ~1.07x NTA (using the $218mil from the HY). The market doesn't want to dilute that ROA too much. I think MNY is all about ROA and how much your paying for the loan book.

I'm looking for MNY to retain earnings to grow the loan book which will minimize borrowings, improve ROA and warrant a higher premium to NTA.

Expand

I can understand the book value being the biggest driver of the share price given MNY is a lender. Though, at what point does the projected growth of that loan book and the increased profits from it factor into a share price? Apparently not at all.

MNY Price at posting: $1.51 Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 48, 2024

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

There are more pages in this discussion • 7 more messages in this thread...

First 6 Last

Add MNY (ASX) to my watchlist

I can understand the book value being the biggest driver of the...

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 48, 2024

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Parkes Au-Cu project to 'transform' Adavale Resources with key targets